Apotex Inc - Strategic SWOT Analysis Review

January 2019 | 29 pages | ID: A43BFC886ADEN
GlobalData

Abstracts

Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. The company also offers biosimilars, active pharmaceutical ingredients and pharmaceuticals. It carries out the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Montreal, Richmond Hill, Brantford, Windsor, Winnipeg, Toronto, Etobicoke, Mississauga, London, Calgary and Vancouver. It serves patients, healthcare providers and payers, governments and other pharmaceutical manufacturers. It operates through subsidiaries, joint ventures and licensing agreements across Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.

Apotex Inc Key Recent Developments

Dec 19,2018: Apotex names Jeff Watson as leader after CEO Jack Kay departs
Aug 10,2018: FDA approves first generic drug under new CGT designation
Aug 08,2018: CannTrust and Apotex accelerate partnership to fuel global expansion in medical cannabis market
May 09,2018: Apotex Announces Proposed Merger of AUS & NZ Operations
Mar 08,2018: Advisory - Chipped pills in additional packages of Alysena 21 and 28 birth control pills

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Apotex Inc - Key Facts
Apotex Inc - Key Employees
Apotex Inc - Key Employee Biographies
Apotex Inc - Major Products and Services
Apotex Inc - History
Apotex Inc - Company Statement
Apotex Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Apotex Inc - Business Description
Apotex Inc - SWOT Analysis
SWOT Analysis - Overview
Apotex Inc - Strengths
Apotex Inc - Weaknesses
Apotex Inc - Opportunities
Apotex Inc - Threats
Apotex Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Apotex Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Aug 10, 2018: FDA approves first generic drug under new CGT designation
Aug 08, 2018: CannTrust and Apotex accelerate partnership to fuel global expansion in medical cannabis market
May 09, 2018: Apotex Announces Proposed Merger of AUS & NZ Operations
Mar 08, 2018: Advisory - Chipped pills in additional packages of Alysena 21 and 28 birth control pills

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Apotex Inc, Key Facts
Apotex Inc, Key Employees
Apotex Inc, Key Employee Biographies
Apotex Inc, Major Products and Services
Apotex Inc, History
Apotex Inc, Subsidiaries
Apotex Inc, Key Competitors
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Apotex Inc, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

Therapure Biopharma Inc
Pfizer Inc
Bausch Health Companies Inc
AIM Therapeutics Inc